2024-01-01 2024-12-31 true No description of principal activity Capium Accounts Production 1.1 12367319 2024-01-01 2024-12-31 12367319 bus:AbridgedAccounts 2024-01-01 2024-12-31 12367319 bus:FRS102 2024-01-01 2024-12-31 12367319 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 12367319 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 12367319 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 12367319 2024-01-01 2024-12-31 12367319 2024-12-31 12367319 bus:RegisteredOffice 2024-01-01 2024-12-31 12367319 core:WithinOneYear 2024-12-31 12367319 core:AfterOneYear 2024-12-31 12367319 1 2024-01-01 2024-12-31 12367319 bus:Director1 2024-01-01 2024-12-31 12367319 bus:Director1 2024-12-31 12367319 bus:Director1 2023-01-01 2023-12-31 12367319 bus:Director2 2024-01-01 2024-12-31 12367319 bus:Director2 2024-12-31 12367319 bus:Director2 2023-01-01 2023-12-31 12367319 2023-01-01 12367319 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 12367319 2023-01-01 2023-12-31 12367319 2023-12-31 12367319 core:WithinOneYear 2023-12-31 12367319 core:AfterOneYear 2023-12-31 12367319 bus:EntityAccountantsOrAuditors 2023-01-01 2023-12-31 12367319 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 12367319 bus:OrdinaryShareClass1 2024-12-31 12367319 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 12367319 bus:OrdinaryShareClass1 2023-12-31 12367319 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 12367319 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 12367319 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 12367319 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 12367319 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 12367319 core:Non-currentFinancialInstruments 2024-12-31 12367319 core:Non-currentFinancialInstruments 2023-12-31 12367319 core:ShareCapital 2024-12-31 12367319 core:ShareCapital 2023-12-31 12367319 core:RetainedEarningsAccumulatedLosses 2024-12-31 12367319 core:RetainedEarningsAccumulatedLosses 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 12367319
England and Wales
MNA LABORATORY LTD
Dormant Accounts
Period of accounts Start date: 01 January 2024 End date: 31 December 2024

MNA LABORATORY LTD Contents Page For the year ended 31 December 2024
Accountants' report | 1
Balance sheet | 2
Notes to the financial statements | 3

MNA LABORATORY LTD Accountants' Report For the year ended 31 December 2024
Accountant’s report You consider that the company is exempt from an audit for the year ended 31 December 2024 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. Oznaz Ltd 31 December 2024 .................................................... Oznaz Ltd Britannia House 11 Glenthorne Road Hammersmith London W6 0LH 12 September 2025 1

MNA LABORATORY LTD Balance Sheet As at 31 December 2024
| Notes | 2024 £ |  | 2023 £
--- | --- | --- | --- | ---
Current assets |  |  |
Cash at bank and in hand |  | 220 |  | 2,165
Creditors: amount falling due within one year |  | (15,429) |  | (15,474)
Net current assets |  | (15,209) |  | (13,309)
Total assets less current liabilities |  | (15,209) |  | (13,309)
Net assets |  | (15,209) |  | (13,309)
Capital and reserves |  |  |
Called up share capital | 1 | 100 |  | 100
Profit and loss account |  | (15,309) |  | (13,409)
Shareholders' funds |  | (15,209) |  | (13,309)
For the year ended 31 December 2024 the company was entitled to exemption from audit under Section 480 of the Companies Act 2006 relating to dormant companies. Directors' responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the profit and loss account has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the board of directors on 12 September 2025 and were signed on its behalf by:
------------------------------- Volkan Akin Director
2

MNA LABORATORY LTD Notes to the Abridged Financial Statements For the year ended 31 December 2024
General Information MNA LABORATORY LTD is a private company, limited by shares, registered in England and Wales, registration number 12367319, registration address 38 Foss Avenue, Croydon, CR0 4EU. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Going concern basis The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted
2. | Share Capital
Allotted, called up and fully paid | 2024 £ |  | 2023 £
--- | --- | --- | ---
100 Class A shares of £1.00 each | 100 |  | 100
| 100 |  | 100
3. | Average number of employees Average number of employees during the year was 0 (2023 : 1).
3